Table 2

Schedule of assessments and outcome measures

Clinical assessmentsPreinterventionInterventionEight weeksPostinterventionTwelve weeks
Informed consentX
Sociodemographic measurementX
ARATXXX
FMA-ULXXX
PROM-ULXXX
MALXXX
FSS-7XXX
SIPSOXXX
smRSqXXX
Pain VASXXX
EQ-5D-5LXXX
CSRIXXX
Training and training questionnaireX
Neurofenix platform useX
Clinical and technical supportX
Postintervention questionnaireXX
Semistructured interviewXX
FallsXXXX
Upper-limb painXXXX
AE and SAEXXXX
  • AE, adverse event; ARAT, Action Research Arm Test; CSRI, Client Service Receipt Inventory; FMA-UL, Fugl-Meyer Assessment-upper limb; FSS-7, seven-item Fatigue Severity Scale; MAL, Motor Activity Log; PROM-UL, passive range of movement-upper limb; SAE, serious adverse event; SIPSO, Subjective Index of Physical and Social Outcome; smRSq, simplified modified Rankin Scale questionnaire; VAS, visual analogue scale; EQ-5D-5L, EuroQol 5 Dimensions 5 Levels.